Cargando…

Circadian Clock Genes Modulate Immune, Cell Cycle and Apoptosis in the Diagnosis and Prognosis of Pan-Renal Cell Carcinoma

Background: Pan-renal cell carcinoma (pan-RCC) is mainly divided into renal clear cell carcinoma (KIRC), renal papillary cell carcinoma (KIRP), and chromophobe cell carcinoma (KICH). Pan-RCC is a common malignant neoplasm with a high incidence and poor prognosis. Several studies have demonstrated a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shuwen, Cheng, Yongxian, Wang, Shaoxiang, Liu, Huiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717949/ https://www.ncbi.nlm.nih.gov/pubmed/34977153 http://dx.doi.org/10.3389/fmolb.2021.747629

Ejemplares similares

A Mathematical Model to Characterize the Role of Light Adaptation in Mammalian Circadian Clock
por: Shi, Yuzeng, et al.
Publicado: (2021)

Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer
por: Zhao, Lianfang, et al.
Publicado: (2023)

Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
por: Lan, Tianfeng, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Associations of TGFBI Expression With Prognosis and Immune Characteristics
por: Chen, Yun, et al.
Publicado: (2021)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma
por: Chu, Guangdi, et al.
Publicado: (2021)

A Pan-Cancer Landscape of HOX-Related lncRNAs and Their Association With Prognosis and Tumor Microenvironment
por: Shao, Wei, et al.
Publicado: (2021)

Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
por: Shu, Xiangjun, et al.
Publicado: (2022)

Baicalin Induces Apoptosis and Suppresses the Cell Cycle Progression of Lung Cancer Cells Through Downregulating Akt/mTOR Signaling Pathway
por: Sui, Xinbing, et al.
Publicado: (2021)

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
por: Liu, Shixian, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell Carcinoma
por: Sun, Si, et al.
Publicado: (2022)

Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases
por: Singh, Shripriya, et al.
Publicado: (2016)

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)

Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
por: Zou, Xiong, et al.
Publicado: (2022)

Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Sun, Lei, et al.
Publicado: (2022)

Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
por: Feng, Huan, et al.
Publicado: (2020)

The Molecular Clock and Neurodegenerative Disease: A Stressful Time
por: Carter, Bethany, et al.
Publicado: (2021)

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy
por: Zhang, Pei, et al.
Publicado: (2020)

KCNN4 is a Potential Biomarker for Predicting Cancer Prognosis and an Essential Molecule that Remodels Various Components in the Tumor Microenvironment: A Pan-Cancer Study
por: Chen, Shaohua, et al.
Publicado: (2022)

Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma
por: Shen, Yuanhao, et al.
Publicado: (2022)

Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort
por: Jia, Chenguang, et al.
Publicado: (2022)

A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy Response
por: Liu, Mengmeng, et al.
Publicado: (2022)

Integrative bioinformatics analysis to identify the effects of circadian rhythm on Crohn’s disease
por: Liu, Dan, et al.
Publicado: (2022)

The Dynamics of Lamin a During the Cell Cycle
por: Vivante, Anat, et al.
Publicado: (2021)

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma
por: Nai, Aitao, et al.
Publicado: (2022)

Identification of Mast Cell-Based Molecular Subtypes and a Predictive Signature in Clear Cell Renal Cell Carcinoma
por: Liu, Hanxiang, et al.
Publicado: (2021)

RelB is a potential molecular biomarker for immunotherapy in human pan-cancer
por: Wu, Jintao, et al.
Publicado: (2023)

A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms
por: Liu, Xiao-Ping, et al.
Publicado: (2020)

An Integrative Pan-Cancer Analysis of PBK in Human Tumors
por: Wen, Huantao, et al.
Publicado: (2021)

ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis
por: Yan, Qiang, et al.
Publicado: (2021)

Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity
por: Chen, Fei, et al.
Publicado: (2022)

Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
por: Liu, Yi, et al.
Publicado: (2021)

The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells
por: Tisi, Renata, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of Heat Shock Protein 110, 90, 70, and 60 Families
por: Yan, Li-rong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1al1h98sv0m0qdlifoao54lfup